02170.HK
Suzhou Basecare Medical Corporation Limited
HKSE · Healthcare · Medical - Devices · CN
HKD 1.38
−2.82%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 260.7M | 233.3M | 299.1M | 208.0M | 140.9M |
| Cost of Revenue | 120.9M | 109.7M | 162.9M | 116.6M | 81.4M |
| Gross Profit | 139.7M | 123.6M | 136.2M | 91.4M | 59.5M |
| Operating Expenses | |||||
| R&D Expense | 82.3M | 106.4M | 135.3M | 129.6M | 119.8M |
| SG&A Expense | 207.3M | 232.0M | 276.4M | 209.3M | 161.5M |
| General & Admin Expense | 95.9M | 121.5M | 164.7M | 105.4M | 81.4M |
| Selling & Marketing Expense | 106.6M | 110.5M | 111.7M | 103.9M | 80.1M |
| Other Expenses | 17.2M | (698.0K) | (44.5M) | (53.8M) | (95.6M) |
| Total Operating Expenses | 306.8M | 337.7M | 367.2M | 285.1M | 185.6M |
| Cost and Expenses | 427.7M | 447.3M | 530.1M | 401.7M | 267.0M |
| Operating Income (EBIT) | (167.0M) | (214.1M) | (231.0M) | (193.7M) | (126.1M) |
| Non-Operating | |||||
| Interest Income | — | 11.8M | 25.3M | 38.5M | 23.6M |
| Interest Expense | — | 13.1M | 9.4M | 2.6M | 496.0K |
| Net Interest Income | (2.4M) | (1.3M) | 15.9M | 35.9M | 23.1M |
| Other Non-Op Income/Expense | (11.3M) | (13.1M) | (9.4M) | (2.6M) | (496.0K) |
| Non-Operating Income (excl Interest) | (22.0M) | (3.3M) | 36.8M | (49.7M) | 89.9M |
| EBT (Pre-Tax Income) | (178.4M) | (227.2M) | (240.3M) | (196.3M) | (126.6M) |
| Income Tax Expense | 4.4M | 3.7M | (3.1M) | (3.0M) | 6.0M |
| Bottom Line | |||||
| Net Income | (174.0M) | (223.5M) | (237.0M) | (191.7M) | (123.2M) |
| Earnings from Cont. Ops | (174.0M) | (223.5M) | (237.2M) | (193.3M) | (132.6M) |
| Earnings from Discont. Ops | — | — | — | — | 9.1M |
| Bottom Line Net Income | (174.0M) | (223.5M) | (237.0M) | (191.7M) | (131.8M) |
| Per Share | |||||
| Basic EPS | (HK$0.64) | (HK$0.82) | (HK$0.87) | (HK$0.70) | (HK$0.45) |
| Diluted EPS | (HK$0.64) | (HK$0.82) | (HK$0.87) | (HK$0.70) | (HK$0.45) |
| Revenue Per Share | HK$0.95 | HK$0.85 | HK$1.09 | HK$0.76 | HK$0.52 |
| Shares | |||||
| Basic Shares Outstanding | 273.5M | 273.5M | 273.5M | 273.5M | 273.5M |
| Diluted Shares Outstanding | 273.5M | 273.5M | 273.5M | 273.5M | 273.5M |
| Profitability Metrics | |||||
| EBITDA | (99.5M) | (167.0M) | (253.3M) | (174.1M) | (117.7M) |
| D&A | 45.5M | 43.8M | 14.5M | 19.6M | 8.4M |
| EBIT | (145.0M) | (210.8M) | (267.8M) | (193.7M) | (126.1M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026